Clinical Trial

Prevention of Parastomal Hernias With a Preformed Three-dimensional, Funnel-shaped Mesh

Study acronym: PREVEMAC
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2024 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Parastomal hernia (PH) remains a significant complication following stoma creation, boasting a considerable prevalence in the range of 30 to 50% within the first year post-surgery, a figure that climbs even higher when considering radiological evidence irrespective of clinical symptoms. A noteworthy one-third of these cases necessitate subsequent surgical interventions, yielding suboptimal outcomes both in the short and long term. The clinical manifestations of PH are diverse, ranging from mild inconveniences like fecal leakage and dermatitis to more severe and potentially life-threatening complications such as intestinal obstruction, hernia incarceration, and ischemia. Various systematic reviews and meta-analyses have advocated for the adoption of prophylactic meshes, although defining precise incidence and recurrence rates has proven challenging due to methodological disparities across studies. Keyhole and modified Sugarbaker techniques dominate laparoscopic and robotic approaches, yet none offer ideal outcomes. The aim of this study is to evaluate the decrease of postoperative parastomal hernia using this three-dimensional, funnel-shaped mesh.
Trial Details
NCT Number NCT06533839
Lead Sponsor Consorci Sanitari Integral
Conditions Parastomal Hernia
Enrollment 58 participants
Start Date 2024-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2029-08-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-01